Leadership

Senior Management Team

Mr. De Backer joined RHEI Pharmaceuticals in November 2007 and has more than 15 years of experience in finance & general management. Prior to joining RHEI, Mr. De Backer worked for three years as an independent consultant providing interim management and strategic consultancy services to high tech start-up companies and spin-offs. Mr. De Backer started his career as Investment Manager at Lessius, a private Belgian investment banker. Between 1997 and 2005 Mr. De Backer served at Spector Photo Group, an independent publicly traded photographic company where he held several positions as Group Financial Controller, Finance & Administration Manager and Business Unit Manager in Belgium, the Netherlands and France.

Joan Chypyha is founder and CEO of Alto Pharmaceuticals a company focused on bringing new health care products and technologies to the Canadian market. She has more than 20 years experience in the pharmaceutical industry in various capacities. Joan was formerly VP of Corporate Development at Barrier Therapeutics Inc., where she was responsible for overseeing all aspects of corporate development including mergers and acquisitions, as well as opportunities to in or out-license products. Prior to taking on the position of VP Ms. Chypyha was the General Manager of Barrier Therapeutics Canada where she was responsible for managing the company and building the business from the ground up. In a period less than 1 year, she was successful in negotiating the rights for three products in Canada; Solage, Vaniqa and Denavir, as well as a co-promotion agreement with Allergan for Botox in hyperhidrosis. Ms. Chypyha began her career in the industry with Hoffmann-La Roche where she held positions of increasing responsibility concluding her 15 year tenure as Business Unit Director for Dermatology. Prior to that, Ms. Chypyha served as Assoc. Director of Business Development. In this capacity she negotiated licensing opportunities and partnerships, conducted due-diligence and worked to develop opportunities within the biotech sector. She has expertise in strategic planning, sales and marketing in various therapeutic areas as well as experience working with government agencies.

Ms. Lian Minjun joined the team of RHEI Pharmaceuticals as General Manager beginning of 2008. Lian Minjun is hired to help RHEI Pharmaceuticals in its development in China and to assist the top management of the company in establishing a well balanced and highly qualified team. Through her expertise in the pharmaceutical area over more than 30 years, Lian Minjun is very well placed to assist RHEI in the regulatory affairs and the setup of clinical trials for its product pipeline. Lian Minjun was born in Shanghai. After graduating from the East-China Chemical & Engineering University, she was first employed at the Xian Pharmaceutical Factory and subsequently moved to Shaanxi Hanjiang Pharmaceutical Ltd. where she worked in different responsibilities to finally become Vice General Manager. Lian Minjun’s expertise in the chemical and pharmaceutical industry includes areas such as GMP compliance, production, foreign trade, technical cooperation and regulatory aspects.